Viewing Study NCT07471503


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-26 @ 10:52 PM
Study NCT ID: NCT07471503
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-13
First Post: 2026-02-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module